Search details
1.
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Wellcome Open Res
; 8: 182, 2023.
Article
in English
| MEDLINE | ID: mdl-38707489
Results
1 -
1
de 1
1
Next >
>>